+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

From the Centers for Disease Control and Prevention. Updated recommendations on the use of pneumococcal conjugate vaccine in a setting of vaccine shortage--Advisory Committee on Immunization Practices



From the Centers for Disease Control and Prevention. Updated recommendations on the use of pneumococcal conjugate vaccine in a setting of vaccine shortage--Advisory Committee on Immunization Practices



JAMA 287(7): 833-834




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 046129343

Download citation: RISBibTeXText

PMID: 11862959


Related references

Updated recommendations on the use of pneumococcal conjugate vaccine in a setting of vaccine shortage Advisory committee on immunization practices. Morbidity & Mortality Weekly Report. 50(50): 1140-1142, Ember 21, 2001

Prevention of pneumococcal disease among infants and children - use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine - recommendations of the Advisory Committee on Immunization Practices (ACIP). Mmwr. Recommendations and Reports 59(Rr-11): 1-18, 2010

From the Centers for Disease Control and Prevention. Updated recommendations from the Advisory Committee on Immunization Practices in response to delays in supply of influenza vaccine for the 2000-01 season. JAMA 284(16): 2050-2052, 2001

Review of recommendations of the Advisory Committee on Immunization Practices, Centers for Disease Control and Prevention, on varicella vaccine. Journal of Infectious Diseases 174 Suppl 3: S342-S344, 1996

From the Centers for Disease Control and Prevention. Use of anthrax vaccine in response to terrorism: supplemental recommendations of the Advisory Committee on Immunization Practices. JAMA 288(21): 2681-2682, 2002

From the Centers for Disease Control and Prevention. Supplemental recommendations on adverse events following smallpox vaccine in the pre-event vaccination program: recommendations of the Advisory Committee on Immunization Practices. JAMA 289(16): 2064-2064, 2003

Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP). Mmwr. Morbidity and Mortality Weekly Report 61(40): 816-819, 2012

Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged ≥65 years: recommendations of the Advisory Committee on Immunization Practices (ACIP). Mmwr. Morbidity and Mortality Weekly Report 63(37): 822-825, 2014

From the Centers for Disease Control and Prevention. Delayed supply of influenza vaccine and adjunct ACIP influenza vaccine recommendations for the 2000-01 influenza season. Advisory Committee on Immunization Practices. JAMA 284(6): 687-688, 2000

Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among children aged 6-18 years with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP). Mmwr. Morbidity and Mortality Weekly Report 62(25): 521-524, 2013

From the Centers for Disease Control and Prevention. Delayed influenza vaccine availability for 2001-02 season and supplemental recommendations of the Advisory Committee on Immunization Practices. JAMA 286(5): 528-529, 2001

Supplement 3. Caring for the Next Generation: Developments in Pediatric Vaccination || Review of Recommendations of the Advisory Committee on Immunization Practices, Centers for Disease Control and Prevention, on Varicella Vaccine. Journal of Infectious Diseases 174: S342-S344, 1996

Licensure of a 13-valent pneumococcal conjugate vaccine (PCV13) and recommendations for use among children - Advisory Committee on Immunization Practices (ACIP), 2010. Mmwr. Morbidity and Mortality Weekly Report 59(9): 258-261, 2010

Updated recommendation from the Advisory Committee on Immunization Practices (ACIP) for use of 7-valent pneumococcal conjugate vaccine (PCV7) in children aged 24-59 months who are not completely vaccinated. Mmwr. Morbidity and Mortality Weekly Report 57(13): 343-344, 2008

Pneumococcal Vaccination Among Medicare Beneficiaries Occurring After the Advisory Committee on Immunization Practices Recommendation for Routine Use Of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine for Adults Aged 65 Years. Mmwr. Morbidity and Mortality Weekly Report 66(27): 728-733, 2017